Skip to main content
. Author manuscript; available in PMC: 2024 Jun 25.
Published in final edited form as: Int J Pharm. 2023 May 18;641:123055. doi: 10.1016/j.ijpharm.2023.123055

Table 6.

Summary of dissolution parameters of API and optimized HME S-SEDDS (mean ± SD; n = 6).

Formulation Q15(%) Q60(%) DE15 DE60 IDR MDR t90% (minutes)
Fenofibrate (pure API) 8.18 ± 0.181 8.445 ± 0.011 4.09 7.29 0.545 0.165 15
Optimized formulation 90.08 ± 0.13 99.15 ± 0.09 45.04 84.69 6.005 1.850 N/A

Q15 and Q60 - drug released in 15 and 60 min; DE15 and DE60 are dissolution efficiency at 15 and 60 min; IDR and MDR are the initial dissolution rate at 15 min and mean dissolution rate respectively: t90% is time at which 90% drug release is achieved.